0000950123-24-012257 Sample Contracts
CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. LICENSE,...License, Research and Collaboration Agreement • December 13th, 2024 • Aktis Oncology, Inc. • Pharmaceutical preparations • New York
This License, Research and Collaboration Agreement (“Agreement”) is entered into as of May 16, 2024 (the “Effective Date”) by and between Aktis Oncology, Inc., a Delaware corporation, with its principal business office at 17 Drydock Avenue, Suite 17-401, Boston, MA 02210 (“Aktis”), and Eli Lilly and Company, an Indiana corporation, with its principal business office located at Lilly Corporate Center, Indianapolis, Indiana 46285 (“Lilly”). Lilly and Aktis are each hereafter referred to individually as a “Party” and together as the “Parties.”
CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. EXCLUSIVE...Exclusive License Agreement • December 13th, 2024 • Aktis Oncology, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXCLUSIVE LICENSE AGREEMENT (the “Agreement”), dated as of November 1, 2021 (the “Effective Date”), is by and between Institute for Protein Innovation, Inc. a Massachusetts nonprofit corporation with an office at 4 Black fan Circle, Boston MA 02115 (“IPI”) and Aktis Oncology Inc., a Delaware corporation, with an office at 450 Kendall Street, 5th Floor, Cambridge, MA 02142 (“Licensee”). Each of IPI and Aktis may be referred to individually as a “Party” and collectively as the “Parties”.